BEAM
Price
$17.25
Change
+$1.02 (+6.28%)
Updated
May 8 closing price
Capitalization
1.63B
95 days until earnings call
DTIL
Price
$5.15
Change
-$0.03 (-0.58%)
Updated
May 8 closing price
Capitalization
54.33M
Ad is loading...

BEAM vs DTIL

Header iconBEAM vs DTIL Comparison
Open Charts BEAM vs DTILBanner chart's image
Beam Therapeutics
Price$17.25
Change+$1.02 (+6.28%)
Volume$3.15M
Capitalization1.63B
Precision BioSciences
Price$5.15
Change-$0.03 (-0.58%)
Volume$69.68K
Capitalization54.33M
BEAM vs DTIL Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. DTIL commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and DTIL is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (BEAM: $17.25 vs. DTIL: $5.15)
Brand notoriety: BEAM and DTIL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 119% vs. DTIL: 44%
Market capitalization -- BEAM: $1.63B vs. DTIL: $54.33M
BEAM [@Biotechnology] is valued at $1.63B. DTIL’s [@Biotechnology] market capitalization is $54.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileDTIL’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • DTIL’s FA Score: 0 green, 5 red.
According to our system of comparison, DTIL is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while DTIL’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • DTIL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, DTIL is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -13.01% price change this week, while DTIL (@Biotechnology) price change was -9.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

DTIL is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.63B) has a higher market cap than DTIL($54.3M). DTIL YTD gains are higher at: 35.171 vs. BEAM (-30.444). DTIL has higher annual earnings (EBITDA): 18.8M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. DTIL (101M). DTIL has less debt than BEAM: DTIL (30.3M) vs BEAM (161M). DTIL has higher revenues than BEAM: DTIL (75.1M) vs BEAM (63.5M).
BEAMDTILBEAM / DTIL
Capitalization1.63B54.3M3,006%
EBITDA-383.98M18.8M-2,042%
Gain YTD-30.44435.171-87%
P/E RatioN/A4.90-
Revenue63.5M75.1M85%
Total Cash851M101M843%
Total Debt161M30.3M531%
FUNDAMENTALS RATINGS
DTIL: Fundamental Ratings
DTIL
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
40
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMDTIL
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVOIX17.720.15
+0.85%
Macquarie Mid Cap Income Opps I
JORCX17.020.06
+0.35%
Janus Henderson Global Select C
AULRX73.52N/A
N/A
American Century Ultra® R
MOJCX13.02N/A
N/A
Donoghue Forlines Momentum C
JERNX11.69-0.09
-0.76%
Janus Henderson Global Real Estate N

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+6.32%
CRSP - BEAM
72%
Closely correlated
+5.52%
NTLA - BEAM
66%
Loosely correlated
+13.58%
RXRX - BEAM
63%
Loosely correlated
+4.77%
PRME - BEAM
59%
Loosely correlated
-7.04%
RCKT - BEAM
58%
Loosely correlated
+11.57%
More

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
-0.58%
AXON - DTIL
46%
Loosely correlated
+14.13%
ORMP - DTIL
41%
Loosely correlated
+3.15%
ARRY - DTIL
39%
Loosely correlated
+9.13%
RENB - DTIL
36%
Loosely correlated
-1.66%
COGT - DTIL
35%
Loosely correlated
+5.51%
More